Open AccessLnc RNA ‐ RMRP promotes nucleus pulposus cell proliferation through regulating miR‐206 expression
Author(s) -
Wang Xuesong,
Peng Lei,
Gong Xiaojin,
Zhang Xiugong,
Sun Ruifu,
Du Jinlong
Publication year - 2018
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/jcmm.13817
Subject(s) - aggrecan , ectopic expression , microbiology and biotechnology , cell growth , chemistry , cell , gene expression , cancer research , biology , gene , pathology , medicine , biochemistry , alternative medicine , osteoarthritis , articular cartilage
Long noncoding RNA s (Lnc RNA s) are involved in the pathogenesis of intervertebral disc degeneration ( IDD ). However, the biological function and expression of RMRP were still unclear. In our study, we showed that RMRP expression was up‐regulated in degenerated NP tissues compared to normal NP samples, and higher RMRP expression was associated with the disc degeneration grade. Further studies indicated that ectopic expression of RMRP enhanced NP cell growth and also enhanced the expression of ki‐67, PCNA and cyclin D1 in the NP cell. Moreover, overexpression of RMRP promoted the expression of Type II collagen and aggrecan and suppressed the expression of MMP 13 and ADAMTS 4. In addition, we found that the expression of miR‐206 was down‐regulated in degenerated NP tissues compared to normal NP samples, and lower miR‐206 expression was correlated with the disc degeneration grade. Interestingly, we indicated that miR‐206 expression in NP tissues was negatively correlated with the expression of RMRP . Ectopic expression of miR‐206 suppressed NP cell proliferation and suppressed the expression of Type II collagen and aggrecan and enhanced the expression of MMP 13 and ADAMTS 4. Furthermore, we demonstrated that overexpression of RMRP increased NP cell growth and regulated ECM expression through targeting miR‐206. These results suggested that lnc RNA ‐ RMRP promoted the progression of IDD through targeting miR‐206, providing an attractive new therapeutic approach for the treatment of IDD disease.